Rivastigmine Tartrate
CNS & Neurology
· SDS & CoA available on request
Overview
A selective MAO-B inhibitor for Parkinson's disease, also used in transdermal and ODT dosage forms.
Specifications
| CAS | 14611-52-0 |
| Standard | USP |
| Category | API |
| Regulatory files | Available on request |
| Therapeutic area | CNS & Neurology |
Regulatory support
Available under NDA for qualified products.
Safety Data Sheet (SDS) & CoA
An SDS and a representative CoA are available for every catalogue product. For your compliance or qualification file, request them by email or the RFQ form — our team releases them together with the documentation package you need.
Request the SDS & CoA by emailRequest documentation & quotation
Specify your target market and annual volume; we'll reply with the relevant dossier and price.
Ask for the dossier
GMPUS FDA inspectedUSP